MORGAN STANLEY PLC/PUT/ZOETIS/175/0.1/17.01.25 | Market Closed - Börse Stuttgart 17:41:25 20/06/2024 BST | ||
| 1.6 EUR | -4.19% |
|
| Current month | +0.63% | ||
| 1 month | +12.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
Latest news about ZOETIS INC.
More news
| Date | Price | Change |
|---|---|---|
| 20/06/24 | 1.6 | -4.19% |
| 19/06/24 | 1.67 | +8.44% |
| 18/06/24 | 1.54 | +3.36% |
| 17/06/24 | 1.49 | -1.32% |
| 14/06/24 | 1.51 | +7.86% |
Delayed Quote Börse Stuttgart
Last update June 20, 2024 at 05:41 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | ZOETIS INC. |
| Issuer | Morgan Stanley |
| WKN | MB3AY1 |
| ISIN | DE000MB3AY13 |
| Date issued | 06/02/2023 |
| Strike | 175 $ |
| Maturity | 17/01/2025 (211 Days) |
| Parity | 10 : 1 |
| Emission price | 2.52 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.09 € |
|---|---|
| Lowest since issue | 0.79 € |
| Spread | 0.03 € |
| Spread % | 1.76% |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
168.2
USD
Average target price
210.2
USD
Spread / Average Target
+24.96%
- Stock Market
- Warrants
- Warrant
